Patent ID: 11896712
Assignee: VERSANTIS AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 10:
11. The method according to claim 1, wherein the liposomes in the liposome composition are uni- and/or multilamellar, and comprise at least one of:
(i) 1 to 100 mol % physiologically acceptable phospholipids;
(ii) 1 to 100 mol % sphingolipids;
(iii) 1 to 100 mol % surfactants;
(iv) 5 to 100 mol % amphiphilic polymers and/or copolymers;
(v) 0 to 60 mol % toxin retention-enhancing compounds; or
(vi) 0 to 30 mol % steric stabilizers.